← Browse by Condition
Medical Condition
nafld non alcoholic fatty liver disease
Total Trials
2
Recruiting Now
2
Trial Phases
Various
ClinicalMetric tracks all active clinical trials for nafld non alcoholic fatty liver disease sourced from ClinicalTrials.gov. Each listing includes the NCT identifier, current recruitment status, phase, primary endpoints, sponsor, estimated enrollment, and participating countries — updated daily as new studies open and status changes.
- Recruiting trials currently enrolling participants, with eligibility criteria and age requirements
- Phase 1–4 studies from early safety trials to post-marketing surveillance
- NIH, pharmaceutical sponsor, and academic medical center studies worldwide
- AI-powered plain-language summary available for every trial listing
Top Sponsors
1 trial
1 trial
NCT07270601
Recruiting
Development of a Quantifiable Ultrasound Biomarker for Hepatic Steatosis
Enrollment
110 pts
Location
United States
Sponsor
ContextVision AB
NCT07093346
Recruiting
The Impact of Pectin Supplementation on Systematic Inflammation Pathway, Gut Microbiome, and Metabolic Health in Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
Enrollment
45 pts
Location
United Kingdom
Sponsor
University of Nottingham
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology